Dysphagia Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Dysphagia is any disruption in the swallowing process during bolus transport from the oral cavity to the stomach. Dysphagia refers either to the difficulty someone may have with the initial phases of a swallow, which is described as oropharyngeal dysphagia (mostly pharynx and proximal esophagus are affected) or to the sensation that foods and/or liquids are being obstructed in their passage from the mouth to the stomach, which is described as esophageal dysphagia (mostly esophageal body and esophagogastric junction are affected). In a few cases, many disorders overlap and can produce both oropharyngeal and esophageal dysphagia.
The Dysphagia marketed and pipeline drugs assessment report provides a data-driven overview of the current and future competitive landscape in Dysphagia therapeutics.
Dysphagia Marketed and Pipeline Drugs Market Overview by Mechanism of Action
The major mechanism of action segments in the Dysphagia marketed and pipeline drugs market are enzyme inhibitor, receptor agonist, receptor antagonist, and enzyme activator.
Dysphagia Marketed and Pipeline Drugs Market Analysis by Mechanism of Action
For more mechanism of action insights, download a free report sample
Dysphagia Marketed and Pipeline Drugs Overview by Route of Administration
The major routes of administration segments in the Dysphagia marketed and pipeline drugs market are oral therapies and injection.
Dysphagia Marketed and Pipeline Drugs Analysis by Route of Administration
For more route of administration insights, download a free report sample
Market Report Scope
Major Mechanism of Action | Enzyme Inhibitor, Receptor Agonist, Receptor Antagonist, and Enzyme Activator |
Major Route of Administration | Oral Therapies and Injection |
Scope
GlobalData’s Dysphagia Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.
Components of the report include:
- Disease Landscape
- Disease Overview
- Epidemiology Overview
- Treatment Overview
- Marketed Products Assessment
- Breakdown by Mechanism of Action, Molecule Type and Route of Administration
- Pipeline Assessment
- Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration
- Late-to-mid-stage Pipeline Drugs
- Clinical Trials Assessment
- Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
- Enrolment Analytics, Site Analytics, Feasibility Analysis
- Deals Landscape
- Mergers, Acquisitions, and Strategic Alliances by Region
- Overview of Recent Deals
- Future Market Catalysts
Reasons to Buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the Dysphagia market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global Dysphagia market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Table of Contents
Frequently asked questions
-
What are the major mechanisms of action in Dysphagia marketed and pipeline drugs assessment market?
The major mechanism of action segments in the Dysphagia marketed and pipeline drugs market are enzyme inhibitor, receptor agonist, receptor antagonist, and enzyme activator.
-
What are the major routes of administration in Dysphagia marketed and pipeline drugs assessment market?
The major routes of administration segments in the Dysphagia marketed and pipeline drugs market are oral therapies and injection.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.